Dermatopathologic features of cutaneous squamous cell carcinoma and actinic keratosis: Consensus criteria and proposed reporting guidelines
- PMID: 36841336
- DOI: 10.1016/j.jaad.2022.12.057
Dermatopathologic features of cutaneous squamous cell carcinoma and actinic keratosis: Consensus criteria and proposed reporting guidelines
Abstract
Background: There is considerable variation in the literature regarding the dermatopathologic diagnostic features of and reporting guidelines for actinic keratosis (AK) and cutaneous squamous cell carcinoma (cSCC).
Objective: To develop consensus recommendations regarding diagnostic criteria, nomenclature, and reporting of AK and cSCC.
Methods: Literature review and cross-sectional multiround Delphi process including an international group of expert dermatopathologists followed by a consensus meeting.
Results: Consensus was achieved regarding the key dermatopathologic features necessary for diagnosing cSCC, AK, and associated variants; grading of degree of cellular differentiation in cSCC; utility of immunohistochemistry for diagnosis of cSCC; and pathologic features that should be reported for cSCC and AK.
Limitations: Consensus was not achieved on all questions considered.
Conclusion: Despite the lack of clarity in the literature, there is consensus among expert dermatopathologists regarding diagnostic criteria and appropriate reporting of AK and cSCC. Widespread implementation of these consensus recommendations may improve communication between dermatopathologists and clinicians, facilitating appropriate treatment of AK and cSCC.
Keywords: actinic keratosis; consensus; diagnosis; immunohistochemistry; international; pathology; squamous cell carcinoma.
Copyright © 2023 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflicts of interest None disclosed.
Similar articles
-
Differential proteomic analysis of actinic keratosis, Bowen's disease and cutaneous squamous cell carcinoma by label-free LC-MS/MS.J Dermatol Sci. 2018 Jul;91(1):69-78. doi: 10.1016/j.jdermsci.2018.04.006. Epub 2018 Apr 10. J Dermatol Sci. 2018. PMID: 29665991
-
Targeted deep sequencing reveals genomic alterations of actinic keratosis/cutaneous squamous cell carcinoma in situ and cutaneous squamous cell carcinoma.Exp Dermatol. 2023 Apr;32(4):447-456. doi: 10.1111/exd.14730. Epub 2022 Dec 26. Exp Dermatol. 2023. PMID: 36533870
-
Expression of MCM2 as a Proliferative Marker in Actinic Keratosis and Cutaneous Squamous Cell Carcinoma.In Vivo. 2022 May-Jun;36(3):1245-1251. doi: 10.21873/invivo.12823. In Vivo. 2022. PMID: 35478139 Free PMC article.
-
From actinic keratosis to cutaneous squamous cell carcinoma: the key pathogenesis and treatments.Front Immunol. 2025 Jan 24;16:1518633. doi: 10.3389/fimmu.2025.1518633. eCollection 2025. Front Immunol. 2025. PMID: 39925808 Free PMC article. Review.
-
Core Outcome Set for Actinic Keratosis Clinical Trials.JAMA Dermatol. 2020 Mar 1;156(3):326-333. doi: 10.1001/jamadermatol.2019.4212. JAMA Dermatol. 2020. PMID: 31939999
Cited by
-
Skin microbiome influences the progression of cutaneous squamous cell carcinoma through the immune system.World J Surg Oncol. 2025 Apr 9;23(1):129. doi: 10.1186/s12957-025-03791-5. World J Surg Oncol. 2025. PMID: 40205611 Free PMC article. Review.
-
Advanced and Metastatic Non-Melanoma Skin Cancer: Epidemiology, Risk Factors, Clinical Features, and Treatment Options.Biomedicines. 2024 Jun 28;12(7):1448. doi: 10.3390/biomedicines12071448. Biomedicines. 2024. PMID: 39062023 Free PMC article. Review.
-
Cutaneous Squamous Cell Carcinoma: An Updated Review.Cancers (Basel). 2024 May 8;16(10):1800. doi: 10.3390/cancers16101800. Cancers (Basel). 2024. PMID: 38791879 Free PMC article. Review.
-
Grading differentiation in cutaneous squamous cell carcinoma: a review of the literature.Arch Dermatol Res. 2024 Jun 27;316(7):434. doi: 10.1007/s00403-024-03184-w. Arch Dermatol Res. 2024. PMID: 38935165 Review.
-
Innovation in Actinic Keratosis Assessment: Artificial Intelligence-Based Approach to LC-OCT PRO Score Evaluation.Cancers (Basel). 2023 Sep 7;15(18):4457. doi: 10.3390/cancers15184457. Cancers (Basel). 2023. PMID: 37760425 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical